Hemostasis Today

May, 2026
May 2026
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Shashank Joshi: Antiphospholipid Antibodies and Risk of Thrombotic Cardiovascular Events
May 12, 2026, 13:49

Shashank Joshi: Antiphospholipid Antibodies and Risk of Thrombotic Cardiovascular Events

Shashank Joshi, Endocrine Physician at Lilavati Hospital And Research Centre, shared a post on LinkedIn about a recent article by Sina Rashedi et al., published in Nature Reviews Cardiology, adding:

Nature Reviews Cardiology: Antiphospholipid antibodies (aPL) are associated with an elevated risk of thromboembolic events in patients with antiphospholipid syndrome and, increasingly, in those without previous thrombosis.

In this Review, the authors discuss the clinical relevance of aPL seropositivity in predicting the risk of thrombotic cardiovascular events, summarize potential management strategies and identify key knowledge gaps that warrant further research.”

Title: Antiphospholipid antibodies and cardiovascular thrombosis

Authors: Sina Rashedi, Hannah Leyva, Saman A. Siddiqui, Syed Bukhari, Mariana B. Pfeferman, Nathan W. Watson, Francisco Ujueta, Mehrdad Zarghami, Bassil Bacare, Yogendra Kanthi, David Jimenez, Manuel Monreal, Deborah M. Siegal, Geoffrey D. Barnes, John W. Eikelboom, Michelle L. O’Donoghue, Christian T. Ruff, Mattia Galli, Brittany N. Weber, Samuel Z. Goldhaber, Sacha Uljon, Saskia Middeldorp, Renato D. Lopes, David A. Garcia, Gregory Y. H. Lip, Jeffery I. Weitz, Jean M. Connors, Harlan M. Krumholz, Jason S. Knight, Giuseppe Lippi, Mitchell S. V. Elkind, Mary Cushman, Karen H. Costenbader, Gregory Piazza, Behnood Bikdeli

Shashank Joshi: Antiphospholipid Antibodies and Risk of Thrombotic Cardiovascular Events

Stay updated on all scientific advances with Hemostasis Today.